Clinical characteristics | TMM, n = 96 | Non-TMM, n = 98 | t/χ 2 | P |
---|---|---|---|---|
Gender [n (%)] | ||||
Male | 84(87.50) | 82(83.67) | 0.575 | 0.448 |
Female | 12(12.50) | 16(16.33) | ||
Age (year, mean ± standard deviation) | 42.03 ± 8.53 | 42.88 ± 8.77 | 0.681 | 0.497 |
Degree of education [n (%)] | ||||
Junior college and above | 53(55.21) | 56(57.14) | 0.074 | 0.964 |
Middle school and high school | 41(42.71) | 40(40.82) | ||
Primary school and below | 2(2.08) | 2(2.04) | ||
Profession[n (11)] | ||||
Staff members of government organs and public institutions | 19(19.79) | 18(18.37) | 0.092 | 0.955 |
Management personnel of enterprises and public institutions | 26(27.08) | 26(26.53) | ||
Enterprise staffs | 51(53.13) | 54(55.10) | ||
Residence[n (11)] | ||||
Cities and towns | 67(69.79) | 68(69.39) | 0.004 | 0.951 |
Villages | 29(30.21) | 30(30.61) | ||
Diabetes | 2(2.08) | 3(3.06) | 0.185 | 0.667 |
Impaired fasting glucose/ impaired glucose tolerance | 1(1.04) | 2(2.04) | 0.318 | 0.573 |
High blood pressure | 3(2.13) | 2(2.04) | 0.227 | 0.634 |
Liver function index | ||||
ALT(u/L) | 37.50 ± 20.67 | 36.95 ± 22.69 | -0.177 | 0.860 |
γ-glutamyl transpeptidase (u/L) | 53.31 ± 37.86 | 54.26 ± 44.07 | 0.160 | 0.873 |
AST(u/L) | 25.17 ± 8.32 | 25.59 ± 9.69 | 0.974 | 0.744 |
Imaging diagnosis basis [n (%)] | ||||
(1)+(2) | 36 (37.50) | 39 (39.80) | 0.572 | 0.751 |
(1)+(3) | 46 (47.92) | 42 (42.86) | ||
(1)+(2)+(3) | 14 (14.58) | 17 (17.34) |